Wedbush keeps Biogen and Etsy at Neutral, lifts both price targets
Wedbush kept Neutral ratings on Biogen and Etsy and raised price targets to $225 and $99 respectively, according to a TradingView report on October 29.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Wedbush kept its Neutral rating on Biogen and raised its price target from $212 to $225, a gain of 6.1%. According to TradingView, the new target implies a 7.8% downside from the October 28 close of $244.05.
For Etsy, Wedbush also held a Neutral rating and lifted its target from $88 to $99, a 12.5% increase. The new target points to a 7.2% upside from the October 28 close of $92.35.
Over the past 30 days, the five latest analyst notes on Biogen carried targets between $230 and $290, while those on Etsy ranged from $80 to $110. Reference data is provided by Benzinga.
why it matters
Rating reviews like these usually concern only the stocks of individual companies and rarely move the broader market. For Biogen and Etsy holders, the stocks' reaction to the companies' own results will matter more than one broker's target.
tags
instruments
sources
- Wedbush maintains Biogen at Neutral, raises price target to $225 from $212 — TradingView, 29 October 2026 at 14:42 UTC
- Wedbush maintains Etsy at Neutral, raises price target to $99 from $88 — TradingView, 29 October 2026 at 14:56 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗